Shorter steroid regimen may prevent chemo allergies just as well
NCT ID NCT03598426
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested three ways of giving the steroid dexamethasone to prevent allergic reactions from the chemotherapy drug paclitaxel in 90 women with breast or gynecologic cancer. One group took oral dexamethasone the night before and morning of treatment, another got it intravenously just before chemo, and a third got both. The goal was to see if the shorter IV-only method works as well as the standard longer oral course, which could make pre-treatment easier for patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dexamethasone (a steroid drug)
What this could lead to
If it works, this could show that a simpler, shorter IV steroid regimen is just as good as the standard longer oral course for preventing allergic reactions to paclitaxel.
What could go wrong
This is a small, single-center study with only 90 patients, so results may not apply to everyone. Also, it compares different ways of giving the same drug, so no new treatment is being discovered.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Loma Linda University Cancer Center
Loma Linda, California, 92354, United States